Full Press Release Details
NEW YORK, March 22, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Lifecore Biomedical, Inc. (“Lifecore” or the “Company”) (NASDAQ: LFCR) on behalf of Lifecore stockholders. Our investigation concerns whether Lifecore has violated the federal securities laws and/or engaged in other unlawful business practices.
Click here to participate in the action.
On March 20, 2024, Lifecore filed its Annual Report on Form 10-K for the fiscal year ended May 28, 2023, which contained restatements of certain previously issued financial statements that corrected “errors involving the calculation of capitalized interest, valuation of inventories, and certain other adjustments related to previously divested businesses.”
On this news, the price of Lifecore shares declined by $2.18 per share, or approximately 30.32%, from $7.19 per share on March 19, 2024 to close at $5.01 on March 20, 2024.
If you purchased or otherwise acquired Lifecore shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at investigations@bespc.com, by telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.
About Bragar Eagel & Squire, P.C.:
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact Information:
Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Marion Passmore, Esq.